Adams Harkness Cuts Cytyc to 'Market Perform'

Analyst Ryan Rauch says visibility is limited for this maker of diagnostics products

Adams Harkness downgraded Cytyc (CYTC ) to market perform from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.